Skip to main content
SpringerLink
Log in

Neues zu Hämochromatose und M. Wilson

Update on hemochromatosis and Wilson disease

  • Schwerpunkt
  • Published:
Die Gastroenterologie Aims and scope

Zusammenfassung

Der M. Wilson und die HFE-assoziierte Hämochromatose sind autosomal-rezessiv vererbte Stoffwechselkrankheiten der Leber. Kenntnisse hinsichtlich der aktuellen Diagnostik und Therapie sind wichtig, um die Erkrankungen zielgerichtet zu diagnostizieren und die Patienten optimal behandeln zu können. Auch wenn beide Erkrankungen selten sind, hat es in den letzten Jahren spannende neue Erkenntnisse und insbesondere beim M. Wilson verordnungsrelevante neue therapeutische Entwicklungen gegeben.

Abstract

Wilson disease and HFE-associated hemochromatosis are autosomal recessive metabolic diseases of the liver. Knowledge of current developments regarding diagnostics and therapy is relevant for correct diagnosis and optimal treatment of the patients. Even though both diseases are rare, there have been in recent years exciting new findings and new therapeutic developments, especially in Wilson disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Adams PC, Reboussin DM, Press RD et al (2007) Biological variability of transferrin saturation and unsaturated iron-binding capacity. Am J Med 120:999.e1–999.e7

    Article  PubMed  Google Scholar 

  2. Bardou-Jacquet E, Laine F, Guggenbuhl P et al (2017) Worse outcomes of patients with HFE Hemochromatosis with persistent increases in transferrin saturation during maintenance therapy. Clin Gastroenterol Hepatol 15:1620–1627

    Article  PubMed  Google Scholar 

  3. Bardou-Jacquet E, Morandeau E, Anderson GJ et al (2020) Regression of fibrosis stage with treatment reduces long-term risk of liver cancer in patients with hemochromatosis caused by mutation in HFE. Clin Gastroenterol Hepatol 18:1851–1857

    Article  CAS  PubMed  Google Scholar 

  4. Chhikara C, Pai HV, Pai CG (2021) Kayser-Fleischer-like rings in patients with hepatic disease. Indian J Ophthalmol 69:1084–1087

    Article  PubMed  PubMed Central  Google Scholar 

  5. Coffey AJ, Durkie M, Hague S et al (2013) A genetic study of Wilson’s disease in the United Kingdom. Brain 136:1476–1487

    Article  PubMed  PubMed Central  Google Scholar 

  6. Eisenbach C, Sieg O, Stremmel W et al (2007) Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol 13:1711–1714

    Article  PubMed  PubMed Central  Google Scholar 

  7. European Association for Study Of L (2012) EASL clinical practice guidelines: Wilson’s disease. J Hepatol 56:671–685

    Article  Google Scholar 

  8. European Association for the Study of the Liver., Electronic Address EEE, European Association for the Study of The L (2022) EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol 77:479–502

    Article  Google Scholar 

  9. Fang WY, Abuduxikuer K, Shi P et al (2021) Pediatric Wilson disease presenting as acute liver failure: prognostic indices. World J Clin Cases 9:3273–3286

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ferenci P, Caca K, Loudianos G et al (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139–142

    Article  PubMed  Google Scholar 

  11. Gao J, Brackley S, Mann JP (2019) The global prevalence of Wilson disease from next-generation sequencing data. Genet Med 21:1155–1163

    Article  CAS  PubMed  Google Scholar 

  12. Guillaud O, Brunet AS, Mallet I et al (2018) Relative exchangeable copper: a valuable tool for the diagnosis of Wilson disease. Liver Int 38:350–357

    Article  CAS  PubMed  Google Scholar 

  13. Guyader D, Jacquelinet C, Moirand R et al (1998) Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 115:929–936

    Article  CAS  PubMed  Google Scholar 

  14. Laine F, Ruivard M, Loustaud-Ratti V et al (2017) Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: a randomized controlled study in 274 patients. Hepatology 65:465–474

    Article  CAS  PubMed  Google Scholar 

  15. Merle U, Schaefer M, Ferenci P et al (2007) Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut 56:115–120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nicastro E, Ranucci G, Vajro P et al (2010) Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 52:1948–1956

    Article  PubMed  Google Scholar 

  17. Nowak A, Giger RS, Krayenbuehl PA (2018) Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of hepatocellular carcinoma in the Swiss hemochromatosis cohort: a prospective longitudinal observational study. Medicine 97:e12886

    Article  PubMed  PubMed Central  Google Scholar 

  18. Olynyk JK, Cullen DJ, Aquilia S et al (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724

    Article  CAS  PubMed  Google Scholar 

  19. Poujois A, Trocello JM, Djebrani-Oussedik N et al (2017) Exchangeable copper: a reflection of the neurological severity in Wilson’s disease. Eur J Neurol 24:154–160

    Article  CAS  PubMed  Google Scholar 

  20. Proost R, Cassiman D, Levtchenko E et al (2020) Fulminant wilson disease in children: recovery after plasma exchange without transplantation. J Pediatr Gastroenterol Nutr 71:720–725

    Article  CAS  PubMed  Google Scholar 

  21. Sabhapandit S, Kulkarni A, Soumya TR et al (2023) Presence of pseudo-Kayser-Fleischer rings in patients without Wilson disease: a prospective cohort study. Hepatol Commun. https://doi.org/10.1097/HC9.0000000000000136

    Book  Google Scholar 

  22. Schilsky ML, Roberts EA, Bronstein JM et al (2022) A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. https://doi.org/10.1002/hep.32801

    Article  PubMed  Google Scholar 

  23. Vandriel SM, Ayoub MD, Ricciuto A et al (2020) Pediatric Wilson disease presenting as acute liver failure: an individual patient data meta-analysis. J Pediatr Gastroenterol Nutr 71:e90–e96

    Article  PubMed  Google Scholar 

  24. Wallace DF, Dooley JS (2020) ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet 139:1065–1075

    Article  CAS  PubMed  Google Scholar 

  25. Weiss KH, Askari FK, Czlonkowska A et al (2017) Bis-choline tetrathiomolybdate in patients with Wilson’s disease: an open-label, multicentre, phase 2 study. Lancet Gastroenterol Hepatol 2:869–876

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin IV, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland

    Uta Merle

Authors
  1. Uta Merle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uta Merle.

Ethics declarations

Interessenkonflikt

U. Merle war als Referent für die Fa. Univar tätig und erhielt hier ein Vortragshonorar.

Für diesen Beitrag wurden von der Autorin keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Merle, U. Neues zu Hämochromatose und M. Wilson. Gastroenterologie 18, 360–370 (2023). https://doi.org/10.1007/s11377-023-00724-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-023-00724-0

Schlüsselwörter

Keywords

Search

Navigation